expression of BMPR2 [54, 55] . During VSD conditions, elevated levels of GJA1 and SOX9 138 overlap with reduced expression of miR-1-1, and elevate miR-181c [15] . Additional data form Li 139 et al., showed that let-7e-5p, miR-222-3p and miR-433 maybe the underlying cause for 140 abnormalities since they target NOTCH1, HAND1, GATA3 , and ZFPM2 resulting in altered 141 morphogenesis and VSD [27] . 142
DiGeroge syndrome is a direct result of deletion in region 8 of chr:22, thereby producing 143 loss-of-function mutation on TBX1 culminating in haploinsufficiency. TBX1 is has a role in 144 differentiation of the neural crest cells, where mutated TBX1 hinders correct formation of the 145 outflow track [15] . In addition, this condition leads to DGCR8 downregulation and promotes an 146 accumulation of both pri-miR's and pre-miR's [56] . 147
Recently, studies in Down syndrome (CHD expectancy 50~60%) have confirmed 5 miR's 148 to be directly correlated miR-99a, let-7c, miR-125b-2, miR-155 and miR-802, all linked to over 149 expression in the heart [57] . miR-99a has been associated with repression of cardiogenesis when 150 expressed at early stage by regulating Smarca5, let-7c was found to induce it, but only if expressed 151 during mesoderm formation, thereby repressing the activity of Ezh2 [58] . Additional studies in 152 cancer biology have concluded that the loss of the let-7 family contributes to the upregulation ofconducted suggest a mechanism by repressing receptor interacting protein 1 (RIP1), which is 156 independent of both the Wnt/-catenin and Akt survival pathways [15, 59, 60] . miR-155 is involved 157 in many know aspects of regulatory biology: promoting cell proliferation by PTEN signaling 158 pathway [29] , promoting tumor growth by ARID2 repression [61] , regulating cell proliferation in 159 glioma by targeting FOXO3a [62] . 160
According to the AHA website (http://www.heart.org/) "Atherosclerosis is a big word for 161 a big problem". They define, atherosclerosis as buildup of fat deposits turning into plaques in the 162 arteries. A multidimensional problem, not only dependent on the amount of circulating fat, but 163 also on factors such as endothelial cell (EC) dysfunction, vascular smooth muscle cell (VSMC) 164 differentiation and inflammation. These buildups can lead to partial or full blockage, and thus 165 restricting blood flow, nutrition, and/or oxygen. Consequently, being the initiator of many diseases 166 such as CHD, angina, carotid artery disease amongst others [63] . A major component of 167 atherosclerosis, are the EC dysfunction as response to sheer stress. Schober et al., deciphered that 168 mir-126 directly affected vascular integrity, leading to the notion that miR-126-5p was mainly 169 responsible for EC repair by inhibiting NOTCH1 and Dlk1, [64] . Additionally, a second isoform 170 miR-126-3p, is responsible for reducing inflammation signaling by promoting VCAM1. By 171 blocking these 2 mechanisms atherosclerosis protection at the EC level is reduced [65, 66] . 172
Romano's group led to the mechanics of understating the cascade activation of miR-126-5p by 173 Lipoxin A4. A response via pro-inflammatory endothelial microvesicles packed with miR-126-5p. 174
An antagonizing effect to TNF, leading to the upregulation of VCAM1 and the downregulation 175 of SPRED1 [64] . Another component of atherosclerosis mentioned is VSMC differentiation. miR-176 145 deficiency has shown to reduce the medial layer in arteries. In addition, differentiation genes 177 myocardin, KLF4, KLF5, calmodulin kinase, cholesterol transporter ABCA1 were found to be a 178 direct target of miR-145 [67] . 179 miR-33a and miR-33b have been shown to be in regulation of ABCA1 and ABCG1as they 180 control the sterol regulatory element-binding proteins, hence their control can be a useful tool in 181 potential therapies for dyslipidemia and atherosclerosis [68, 69] . Hypertension or high blood 182 pressure can lead to atherosclerosis due to the added force at the artery walls/ miR-145/-143 seems 183
to play an important role in high blood pressure, mainly, having as target the angiotensin Caspase-3 levels, and upregulating Bcl-2 we can find an apoptotic target to miR-320 IGF-1. Note 235 that in inhibition of miR-320 up-regulates the level of IGF1 mRNA (Sun et al., 2017) . Also the 236 anti-apoptotic signaling is the downregulation of miR-200c, as it increases levels of Bcl2 [90] . Table 2) . 293
Attempts to try and direct mimetics and antagomiRs to a specific organ poses a fascinating 294 challenge, a direct attempt to inject the antagomiR to the organ is usually the best shot and delivery 295 system range from the use of liposome vesicles, polymers, and other viral particles, yet for the 296 patient this could lead to potential high costs [101] . The first set of experiments using antagomiR 297 was deemed to observe the systematic reduction of miR's. Intravenous administrations was done 298 against miR-16, miR-122, miR-192 and miR-194 resulting in a striking decline of the resultant 299 miRNA levels in liver, lung, kidney, heart, intestine, fat, skin, bone marrow, muscle, ovaries and 300
adrenals [102]. Further studies have revealed the value of miR's to downregulate miRNAs in 301
primates, using LNA modification [103], the first set of clinical trials (~20) are currently underway 302 using diverse delivery systems [17] . 303
Previously it was mentioned that miR's can have many potential targets, taking this notion 304 let's consider the well documented case of miR-29. miR-29 can regulate fibrosis in the heart by 305 targeting a whole set of different components such as elastins, fibrillins and collagens; all 306 components of the ECM. Therefore by using a well design antagomiR to miR-29, the group was of plaque size and enhanced vasculature, AntagomiR (miR-145) was used rodents. Results showed 320 a marked reduction in plaque in aortic sinuses, necrotic core, increase collagen promoting 321 contractile VSMC [67, 99] . These studies demonstrated how using the antagomiR or the mir-322 mimic, it's possible to achieve a preferred outcome. 323
324
Since their initial discovery, small non-coding RNA's, have played an instrumental role in 325 deciphering the nature and mechanics of human biology and its conditions. As we have seen in 326 this overview of CVD's they are instrumental both in the way they orchestrate through positive 327 and negative feedbacks, and direct control. Ultimately, we see that they work in groups, many of 328 these belonging to a family or super family of miR's, which ultimately in the right balance are 329 responsible for the correct cardiac environment. We can look forward into the next couple of years, 330 where technological advances, will take us further in understanding and uncovering more insights 331 into miR's, mimics and antagomiRs, it's very likely that their local use will be a way of 332 personalized treatment in many illnesses we face. In addition, we expect an even faster uptake of 333 the clinics in using screening methods for identifying miR level in patients as a way to easily access 334 disease information. 
